Spanish Red Biotech Pipeline

MSD

Pembrolizumab / Olaparib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Study of Olaparib Plus Pembrolizumab versus Chemotherapy Plus Pembrolizumab after induction of Clinical Benefit With First-line Chemotherapy Plus Pembrolizumab in Participants with locally recurrent inoperable or Metastatic Triple Negative Breast Cancer
Phase: 2Phase II in Spain, 1Phase I